Drug Trial Radar · NCT05667974
A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried
Last checked: Nov 20, 2026Latest source record: Jul 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4,500
Actual
Start
Sep 22, 2023
Primary completion
Mar 22, 2024
Study completion Feb 21, 2025
Sponsor
- Lead sponsor
- Yisheng Biopharma (Singapore) Pte. Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 29, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase III, randomized, comparator-controlled, double-blind, multicenter study to evaluate lot-to-lot consistency of three lots of a PIKA Rabies Vaccine, immunogenicity and safety in healthy adults using a post-exposure prophylaxis schedule. It is also the aim of this study to evaluate non-inferiority and superiority of the PIKA Rabies Vaccine compared to the rabies vaccine comparator ChiroRab.
Conditions
- Rabies
- Prevention
Interventions
PIKA Rabies Vaccine (Vero Cell) for Human use, Freeze-driedBiological
PIKA rabies vaccine
ChirorabBiological
Active Comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary ImmunogenicityTime frame: 14 days post-vaccination
- Primary ImmunogenicityTime frame: 14 days post-vaccination
- Co-primary Safety(solicited AEs)Time frame: 7 days after each vaccination.
- Co-primary Safety(unsolicited AEs)Time frame: From day of first vaccination through 14 days after the last vaccination
- Co-primary Safety(SAEs)Time frame: through study completion, an average of 1 year
- Co-primary SafetyTime frame: through study completion, an average of 1 year
Locations
7 sites in 2 countries. Site status is shown where the registry gives one.
Al-Shifa Trust Eye Hospital
Islamabad, Pakistan
Ziauddin University
Karachi, Pakistan
Central Park Teaching Hospital
Lahore, Pakistan
TDF-Lakeview,Muntinlupa
City of Muntinlupa, Philippines
Las Pinas Doctor's Hospital
Las Piñas, Philippines
PGH
Manila, Philippines
TDF - San Pablo, Laguna
San Pablo, Philippines
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.